Pelvis and extremity osteosarcoma with similar tumor volume have an equivalent survival

Journal of Surgical Oncology

Volumn 101, Issue 7, 2010, Pages 611-617

  Song, Won Seok ^a   Cho, Wan Hyeong ^a   Jeon, Dae Geun ^a   Kong, Chang Bae ^a   Kim, Min Suk ^a   Lee, Jun A H ^a   Eid, Ahmed Shawky ^b   Kim, Jae Do ^c   Lee, Soo Yong ^a  

^a Korea Cancer Center Hospital   (South Korea)

^b AIN SHAMS UNIVERSITY   (Egypt)

^c Kosin University   (South Korea)

Author keywords

Osteosarcoma; Pelvis; Prognosis; Surgery; Tumor volume

Indexed keywords

CISPLATIN; DOXORUBICIN; METHOTREXATE;

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER SURGERY; CANCER SURVIVAL; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG MEGADOSE; EXTREMITY OSTEOSARCOMA; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MALE; METASTASIS; MULTIPLE CYCLE TREATMENT; OSTEOSARCOMA; PELVIS OSTEOSARCOMA; PRIORITY JOURNAL; PROGNOSIS; SCHOOL CHILD; TREATMENT RESPONSE; TUMOR VOLUME;

ADOLESCENT; ADULT; AGED; BONE NEOPLASMS; CASE-CONTROL STUDIES; CHILD; EXTREMITIES; FEMALE; HUMANS; MALE; MATCHED-PAIR ANALYSIS; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOADJUVANT THERAPY; OSTEOSARCOMA; PELVIC BONES; PROGNOSIS; SURVIVAL ANALYSIS;

EID: 77952071805     PISSN: 00224790     EISSN: 10969098     Source Type: Journal    
DOI: 10.1002/jso.21540     Document Type: Article

References (27)

1. Fahey M, Spanier SS, Vander Griend RA: Osteosarcoma of the pelvis. A clinical and histopathological study of twenty-five patients. J Bone Joint Surg Am 1992;74:321-330.
2. Ham SJ, Kroon HM, Koops HS, Hoekstra HJ: Osteosarcoma of the pelvis-oncological results of 40 patients registered by The Netherlands Committee on Bone Tumours. Eur J Surg Oncol 2000;26:53-60.
3. Grimer RJ, Carter SR, Tillman RM, et al.: Osteosarcoma of the pelvis. J Bone Joint Surg Br 1999;81:796-802.
4. Bielack SS, Kempf-Bielack B, Delling G, et al.: Prognostic factors in high-grade osteosarcoma of the extremities or trunk: an analysis of 1,702 patients treated on neoadjuvant cooperative osteosarcoma study group protocols. J Clin Oncol 2002;20:776-790.
5. Kawai A, Huvos AG, Meyers PA, Healey JH: Osteosarcoma of the pelvis. Oncologic results of 40 patients. Clin Orthop Relat Res 1998;348:196-207.
6. Fuchs B, Hoekzema N, Larson DR, et al.: Osteosarcoma of the pelvis: outcome analysis of surgical treatment. Clin Orthop Relat Res 2009;467:510-518.
7. Saab R, Rao BN, Rodriguez-Galindo C, et al.: Osteosarcoma of the pelvis in children and young adults: the St. Jude Children's Research Hospital experience. Cancer 2005;103:1468-1474.
8. Wurtz LD, Peabody TD, Simon MA: Delay in the diagnosis and treatment of primary bone sarcoma of the pelvis. J Bone Joint Surg Am 1999;81:317-325.
9. Aboulafia AJ, Malawer MM: Surgical management of pelvic and extremity osteosarcoma. Cancer 1993;71:3358-3366. (Pubitemid 23148527)
10. Burger EL, Lindeque BG, Sacral and: non-spinal tumors presenting as backache. A retrospective study of 17 patients. Acta Orthop Scand 1994;65:344-346.
11. Windhager R, Karner J, Kutschera HP, et al.: Limb salvage in periacetabular sarcomas: review of 21 consecutive cases. Clin Orthop Relat Res 1996;331:265-276. (Pubitemid 26357717)
12. Matsuo T, Sugita T, Sato K, et al.: Clinical outcomes of 54 pelvic osteosarcomas registered by Japanese musculoskeletal oncology group. Oncology 2005;68:375-381.
13. Davis AM, Bell RS, Goodwin PJ: Prognostic factors in osteosarcoma: a critical review. J Clin Oncol 1994;12:423-431.
14. Bieling P, Rehan N,Winkler P, et al.: Tumor size and prognosis in aggressively treated osteosarcoma. J Clin Oncol 1996;14:848-858. (Pubitemid 26085530)
15. Ozaki T, Flege S, Kevric M, et al.: Osteosarcoma of the pelvis: experience of the Cooperative Osteosarcoma Study Group. J Clin Oncol 2003;21:334-341.
16. Donati D, Giacomini S, Gozzi E, et al.: Osteosarcoma of the pelvis. Eur J Surg Oncol 2004;30:332-340.
17. Enneking WF, Dunham WK, Resection and: reconstruction for primary neoplasms involving the innominate bone. J Bone Joint Surg Am 1978;60:731-746.
18. Rosen G, Marcove RC, Huvos AG, et al.: Primary osteogenic sarcoma: eight-year experience with adjuvant chemotherapy. J Cancer Res Clin Oncol 1983;106:55-67. (Pubitemid 13040824)
19. Enneking WF, Spanier SS, Goodman MA: A system for the surgical staging of musculoskeletal sarcoma. Clin Orthop Relat Res 1980;153:106-120. (Pubitemid 11217753)
20. Mankin HJ, Hornicek FJ, Rosenberg AE, et al.: Survival data for 648 patients with osteosarcoma treated at one institution. Clin Orthop Relat Res 2004;429:286-291.
21. Kim MS, Lee SY, Cho WH, et al.: Effect of increases in tumor volume after neoadjuvant chemotherapy on the outcome of stage II osteosarcoma regardless of histological response. J Orthop Sci 2009;14:292-297.
22. Franzius C, Bielack S, Flege S, et al.: Prognostic significance of (18)F-FDG and (99m)Tc-methylene diphosphonate uptake in primary osteosarcoma. J Nucl Med 2002;43:1012-1017.
23. Franzius C, Daldrup-Link HE, Wagner-Bohn A, et al.: FDG-PET for detection of recurrences from malignant primary bone tumors: comparison with conventional imaging. Ann Oncol 2002;13:157-160. (Pubitemid 34436740)
24. Kleis M, Daldrup-Link H, Matthay K, et al.: Diagnostic value of PET/CT for the staging and restaging of pediatric tumors. Eur J Nucl Med Mol Imaging 2009;36:23-36.
25. Hawkins DS, Rajendran JG, Conrad EU: 3rd. et al.: Evaluation of chemotherapy response in pediatric bone sarcomas by [F-18]-fluorodeoxy-D-glucose positron emission tomography. Cancer 2002;94:3277-3284.
26. Brenner W, Bohuslavizki KH, Eary JF: PET imaging of osteosarcoma. J Nucl Med 2003;44:930-942.
27. Cheon GJ, Kim MS, Lee JA, et al.: Prediction model of chemotherapy response in osteosarcoma by 18F-FDG PET and MRI. J Nucl Med 2009;50:1435-1440.